Me, known for its at-home DNA testing kits, is expected to be obtained by its highest bidder following a bankruptcy auction ...

Regeneron Pharmaceuticals announced on Monday that it will acquire the genetic testing business and most assets of 23andMe ...

The proposed sale is expected to close in the third quarter, subject to approval by the U.S. Bankruptcy Court for the Eastern ...

Regeneron Pharmaceuticals has bought the genetic testing company 23andMe, a company once valued at $6bn, for $256m through a ...

There is nothing more inherently unique and personal to an individual than his or her DNA. Unlike many other types of personal information, a ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of ...

Regeneron Pharmaceuticals is purchasing nearly all assets of the bankrupt genetic testing company, 23andMe, in a deal worth ...

Several lawmakers and officials, including the Federal Trade Commission, had expressed concerns about the safety of consumers' genetic data through 23andMe's sale process. The privacy ombudsman ...

23andMe’s saliva-based testing not only can aid in tracing ... Customers can also submit complaints or concerns directly to regulators like the Federal Trade Commission or state attorneys general, who ...

Genetic testing company 23andMe agreed on Tuesday to allow a court-appointed overseer to take charge of ensuring customers' ...